Why Earnings Season Could Be Great for Intercept (ICPT)
Intercept (ICPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks · 1天前
Did Hedge Funds Make The Right Call On Intercept Pharmaceuticals Inc (ICPT)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which
Insider Monkey · 4天前
Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its secon
GlobeNewswire · 5天前
Intercept Pharmaceuticals (ICPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Intercept (ICPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
Theratechnologies NASH Data And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha · 07/26 08:41
Intercept Pharma higher on activist chatter
A rumor making the rounds says a large activist may be getting involved with Intercept Pharma (NASDAQ:ICPT) to push for sale. Intercept disappointed in lat
seekingalpha · 07/16 19:43
Intercept Pharma 8-K Shows Co. Received Paragraph IV Certification Notice From Apotex Indicated Apotex Submitted To FDA Abbreviated New Drug Application Seeking Approval To Manufacture, Sell Generic Version Of Co.'s Ocaliva
On July 13, 2020, Intercept Pharmaceuticals, Inc. (the “Company”) received a paragraph IV certification notice (the “PIV Notice”) from Apotex Inc. (“Apotex”) indicating that Apotex has
Benzinga · 07/15 21:07
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)